Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Aspen Aerogels, Inc.NYSE: ASPN
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 8.6% from a year ago
Cash & equivalents stood at $175.58M at the end of Q1 FY2026, down 8.6% from a year earlier and up 11.9% from the prior quarter. Over 3 fiscal years it compounded at -17.7% a year.
Context
- Cash & equivalents amounted to 42.8% of total assets at the end of Q1 FY2026, up 8.2 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -8.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 156.86M USD
- Year-over-year change
- -29.0%
- 4-year CAGR
- +19.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 156.86M | -29.0% |
| FY2024 | 2024-12-31 | 220.88M | +58.1% |
| FY2023 | 2023-12-31 | 139.72M | -50.3% |
| FY2022 | 2022-12-31 | 281.34M | +267.5% |
| FY2021 | 2021-12-31 | 76.56M | — |
Cash & Equivalents vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -8.6% is the 6th highest of 10, against a peer median of -4.6%.
- Cash & equivalents amounts to 42.8% of total assets for ASPN, versus a peer median of 4.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Apr 2026 | $319.09M USD | -28.9% | +8.9% | 20.0% | |
| Mar 2026 | $227.43M USD | +763.9% | +107.5% | 4.0% | |
| Mar 2026 | $215.67M USD | +278.8% | +91.2% | 98.5% | |
| Mar 2026 | $175.58M USD | -8.6% | -17.7% | 42.8% | |
| Mar 2026 | CN¥160.2M CNY | -58.1% | +4.7% | 8.3% | |
| Mar 2026 | $81.8M USD | +6.0% | +27.8% | 4.2% | |
| Apr 2026 | $63.67M USD | +1.7% | +11.3% | 3.2% | |
| Feb 2026 | $39.52M USD | -4.6% | +25.6% | 3.5% | |
| Mar 2026 | $30.66M USD | -45.3% | -30.3% | 4.1% | |
| Dec 2025 | €6.98M EUR | -69.4% | -41.2% | 7.7% | |
| Peer median (excluding ASPN) | — | -4.6% | +11.3% | 4.2% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 76.56M | 281.34M | 139.72M | 220.88M | 156.86M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 20.43M | 57.35M | 70M | 109.1M | 35.27M |
| Inventory | 11.99M | 22.54M | 39.19M | 47.55M | 38.25M |
| Other Current Assets | 390K | 8.46M | 17.42M | 31.91M | 11.68M |
| Total Current Assets | 112.15M | 369.69M | 266.33M | 409.45M | 242.05M |
| Property, Plant & Equipment (Net) | 69.31M | 271.21M | 434.44M | 480.13M | 122.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.5M | 2.52M | 2.28M | 5.57M | 42.08M |
| Total Non-current Assets | 70.8M | 273.73M | 436.72M | 485.7M | 164.63M |
| Total Assets | 182.95M | 643.42M | 703.05M | 895.14M | 406.68M |
| Account Payables | 17.44M | 54.73M | 51.09M | 44.36M | 13.24M |
| Short-term Debt | 0 | 0 | 0 | 23.78M | 25.12M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 6.05M | 5.85M | 2.32M | 2.2M | 1.26M |
| Other Current Liabilities | 8.99M | 12.47M | 16.88M | 19.37M | 2.93M |
| Total Current Liabilities | 36.56M | 78.95M | 78.1M | 110.11M | 62.03M |
| Long-term Debt | 0 | 103.58M | 114.99M | 137.09M | 79.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 5M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 17.99M | 117.04M | 136.9M | 170.33M | 109.14M |
| Total Liabilities | 54.55M | 195.98M | 214.99M | 280.44M | 171.16M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (545.05M) | (627.79M) | (673.6M) | (660.23M) | (1.05B) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | (0) | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 128.41M | 447.44M | 488.06M | 614.71M | 235.52M |
| Total Debt | 15.24M | 119.4M | 138.77M | 197.38M | 143.71M |
| Net Debt | (61.33M) | (161.93M) | (951K) | (23.5M) | (13.15M) |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.